Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Rosing

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Haematologica|April 10, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III familiesElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|October 11, 2003
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trialJeanet M Kemmeren, Ale Algra, Joost C M Meijers, et al.
Haematologica|April 28, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiencyElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|September 5, 2008
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia veraMarina Marchetti, Elisabetta Castoldi, Henri M H Spronk, et al.
British Journal of Haematology|December 11, 2002
Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal womenMarinka S Post, Jan Rosing, Marius J Van Der Mooren, et al.
British Journal of Haematology|July 25, 2003
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and womenGuido Tans, Astrid van Hylckama Vlieg, M Christella L G D Thomassen, et al.
Blood|July 26, 2003
Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutationElisabetta Castoldi, Jose W P Govers-Riemslag, Mirko Pinotti, et al.
Thrombosis and Haemostasis|August 3, 2002
Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance testJoyce Curvers, M Christella L G D Thomassen, Janet Rimmer, et al.
British Journal of Haematology|December 21, 2002
Acquired resistance to activated protein C in breast cancer patientsMarten R Nijziel, Rene van Oerle, M Christella, et al.
Blood|December 28, 2007
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationLisbeth F A Maurissen, M Christella L G D Thomassen, Gerry A F Nicolaes, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Haematologica|April 10, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III familiesElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|October 11, 2003
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trialJeanet M Kemmeren, Ale Algra, Joost C M Meijers, et al.
Haematologica|April 28, 2010
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiencyElisabetta Castoldi, Lisbeth F A Maurissen, Daniela Tormene, et al.
Blood|September 5, 2008
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia veraMarina Marchetti, Elisabetta Castoldi, Henri M H Spronk, et al.
British Journal of Haematology|December 11, 2002
Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal womenMarinka S Post, Jan Rosing, Marius J Van Der Mooren, et al.
British Journal of Haematology|July 25, 2003
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and womenGuido Tans, Astrid van Hylckama Vlieg, M Christella L G D Thomassen, et al.
Blood|July 26, 2003
Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutationElisabetta Castoldi, Jose W P Govers-Riemslag, Mirko Pinotti, et al.
Thrombosis and Haemostasis|August 3, 2002
Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance testJoyce Curvers, M Christella L G D Thomassen, Janet Rimmer, et al.
British Journal of Haematology|December 21, 2002
Acquired resistance to activated protein C in breast cancer patientsMarten R Nijziel, Rene van Oerle, M Christella, et al.
Blood|December 28, 2007
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationLisbeth F A Maurissen, M Christella L G D Thomassen, Gerry A F Nicolaes, et al.
Pageof 8